The Natural History of Mucolipidosis Type IV
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 7
- 试验地点
- 1
- 主要终点
- Neuropsychological testing
研究概览
简要总结
The purpose of this study is to define the natural history of Mucolipidosis Type IV and identify potential clinical outcome measures.
详细描述
Mucolipidosis type IV (MLIV) is an autosomal recessive disorder typically characterized by severe psychomotor delay evident by the end of the first year of life and slowly progressive visual impairment during the first decade as a result of a combination of corneal clouding and retinal degeneration. By the end of the first decade of life, and always by their early teens, individuals with typical MLIV develop severe visual impairment as a result of retinal degeneration. MLIV is an under-diagnosed and unique lysosomal disorder in that it often is mistaken either for cerebral palsy or for a retinal dystrophy of unknown cause. In addition, it is caused by a defect in a cation channel rather than by a lysosomal hydrolase. This study represents the only prospective clinical study in this patient population. Now that an animal model has been created and novel therapies will likely be tested, it is particularly important to define the natural history of this disorder and identify potential clinical outcome measures.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 1 Year 至 64 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects must:
- •Have a definitive diagnosis of MLIV based at least on a compatible history and significantly elevated blood gastrin levels
- •Be able to travel to the Baylor Institute of Metabolic Disease in Dallas and spend 2-3 working days on site
- •Be able to tolerate a general exam and neurological exam
- •Be able to tolerate a modest amount of blood drawing, provide a urine specimen, and have a skin biopsy(if not previously done)
- •Be able to tolerate the performance of necessary neuroimaging studies to include EEG and Head MRI
- •Be able to tolerate a neuropsychological testing and rehabilitation evaluation
排除标准
- 未提供
研究组 & 干预措施
Subjects with Mucolipidosis Type IV
结局指标
主要结局
Neuropsychological testing
时间窗: Annual by 5 years
次要结局
- Blood tests(Annual by 5 years)
- Urine tests(Annual by 5 years)
- MRI of the brain(Annual by 5 years)
- Rehabilitation evaluation(Annual by 5 years)
- Nutritional status evaluation(Annual by 5 years)
- Skin biopsy(1 year only)
